Stock listing

Marinomed Biotech Ag

Selected listing: MARI · VIE · EUR · AT

Marinomed Biotech Ag (Vienna:MARI), Health Technology. Latest release Jul 22, 2026: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings…

MARI:VIEEURATUpdated September 19, 2026

Ticker: Vienna:MARI
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Vienna
Currency: EUR

About Marinomed Biotech Ag

Marinomed Biotech AG is a public company listed on the Austrian market under the ticker MARI. Marinomed focuses on developing innovative therapies for viral infections and inflammatory diseases.

Latest news from Marinomed Biotech Ag

Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration

July 22, 2026

Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration

July 16, 2026

Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution

June 29, 2026

Marinomed Biotech : Statement pursuant to § 87 Abs.2 AktG - Thomas Stümmler ( 87 declaration Thomas Stuemmler E)

May 21, 2026

Marinomed Biotech : Form for proxy to IVA (2026 Vollmacht IVA EN FINAL)

May 20, 2026

All Marinomed Biotech Ag news →

Research Marinomed Biotech Ag

Marinomed Biotech Ag company profile

View the public company page for Marinomed Biotech Ag on 6ix.

Marinomed Biotech Ag news

Read company news and market updates connected to Marinomed Biotech Ag.

Marinomed Biotech Ag investor events

Find investor webinars, events, and replay context for Marinomed Biotech Ag.